Financials

  • Market Capitalization 2.03 B
  • Employee 298
  • Founded 2005
  • CEO N/A
  • Website www.syndax.com
  • Headquarter Delaware, United States
  • FIGI BBG000R33JY1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.39
Price to sales ratio
10.56

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1966
HRMY
Harmony Biosciences Holdings, Inc. - Common Stock
35.54 USD-3.53%-5.07%+3.95%+15.02%2.06 B USD
1977
ANAB
AnaptysBio, Inc. - Common Stock
69.81 USD+5.15%+12.18%+23.25%+98.32%2.03 B USD
1987
NUVB
Nuvation Bio Inc. Class A Common Stock
5.76 USD-0.86%+1.41%+14.51%+164.22%2.01 B USD
1989
ABCL
AbCellera Biologics Inc. - Common Shares
6.52 USD-4.12%-21.63%+19.20%+47.85%1.99 B USD

Frequently asked questions about Syndax Pharmaceuticals, Inc. - Common Stock

What is the Syndax Pharmaceuticals, Inc. - Common Stock stock price today?

The current price of Syndax Pharmaceuticals, Inc. - Common Stock (SNDX) is 22.89. Over the past 24 hours, the stock has changed by -3.05%. Follow the SNDX chart for real-time price dynamics.

What is the stock ticker of Syndax Pharmaceuticals, Inc. - Common Stock?

Syndax Pharmaceuticals, Inc. - Common Stock trades under the ticker SNDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Syndax Pharmaceuticals, Inc. - Common Stock stock going up?

SNDX has changed by +2.28% over the last week, +25.63% over the last month, and +131.21% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Syndax Pharmaceuticals, Inc. - Common Stock net income for the last quarter?

Syndax Pharmaceuticals, Inc. - Common Stock reported net income of -42.67 M for the last quarter. The previous quarter showed -68.01 M, which means net income changed by +37.26%.

How many employees does Syndax Pharmaceuticals, Inc. - Common Stock have?

As of the latest available data, Syndax Pharmaceuticals, Inc. - Common Stock has 298 employees. Workforce size can provide additional context about the company's scale and operations.

What is Syndax Pharmaceuticals, Inc. - Common Stock EBITDA?

Syndax Pharmaceuticals, Inc. - Common Stock EBITDA is -31.01 M, and its EBITDA margin is -47.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Syndax Pharmaceuticals, Inc. - Common Stock stock?

You can buy Syndax Pharmaceuticals, Inc. - Common Stock (SNDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Syndax Pharmaceuticals, Inc. - Common Stock stock?

Investing in Syndax Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SNDX chart and related analysis on metatrader.com as part of your research.

News